In order to define a set of markers for the identification of CSCs in hepatoblastoma, we analyzed the expression of CD133, CXCR4, CD34 and CD90 in the hepatoblastoma cell lines HepG2 and HuH6 using flow cytometry. The gene discussed is CD34; the disease is hepatoblastoma.